Robyn M. Scherber

The University of Texas at San Antonio Health Science Center

Also affiliated with Blueprint Medicines (United States), The University of Texas at San Antonio

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Impact of imbalanced gender participation in online myeloproliferative neoplasm symptom surveys.”.

Impact of imbalanced gender participation in online myeloproliferative neoplasm symptom surveys.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e19078

N/A

0DataRank · unranked

5 citations

Gina L. Mazza, Robyn M. Scherber, Holly L. Geyer, Krisstina Gowin, Jeanne Palmer +6 more

Impact of gender representativeness in online symptom survey and clinical trial participation among patients with myeloproliferative neoplasms

Leukemia & lymphoma/Leukemia and lymphoma(2024)10.1080/10428194.2024.2356058

N/A

0DataRank · unranked

3 citations

Amylou C. Dueck, Heidi Kosiorek, Carolyn Mead‐Harvey, Eric A. Meek, Lauren J. Rogak +9 more